Clinical Trial Update: OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial [NA]

View source ↗

Summary

The MEND Trial evaluating OptiMized Resistant Starch for inflammatory bowel disease is listed as active but not recruiting. Target conditions include Crohn's di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Snippet

Sponsor: Children's Hospital of Eastern Ontario | Conditions: Crohn Disease, Ulcerative Colitis | NA | Status: ACTIVE_NOT_RECRUITING